1. PREFACE

1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION

3.1. Context and Background
3.2. Introduction to Cell-based Therapies
3.2.1. Comparison of Cell-based Therapies and Other Biotechnology Products
3.3. Classification of Cell-based Therapy Products
3.4. Overview of Cell Therapy Development and Manufacturing
3.5. Role of Raw Materials in Cell Therapy Development
3.6. Types of Cell Therapy Consumables
3.7. Key Challenges Associated with Cell Therapy Consumables
3.8. Future Perspectives

4. MARKET LANDSCAPE

4.1. Chapter Overview
4.2. Cell Therapy Kit Providers: List of Players
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Location of Kits Preparation Facilities
4.2.5. Analysis by Accreditations Received
4.2.6. Analysis by Type of End-User
4.2.7. Analysis by Type of Cell Therapy
4.2.8. Analysis by Type of Function
4.2.9. Analysis by Scale of Operation
4.2.10. Analysis by Application Area
4.2.11. Logo Landscape: Analysis by Key Players, Scale of Operation and Geography
4.3. Cell Therapy Media Providers: List of Players
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Company Size
4.3.3. Analysis by Location of Headquarters
4.3.4. Analysis by Location of Media Preparation Facilities
4.3.5. Analysis by Accreditations Received
4.3.6. Analysis by Type of End-User
4.3.7. Analysis by Type of Cell Therapy
4.3.8. Analysis by Media Components
4.3.9. Analysis by Type of Function
4.3.10. Analysis by Scale of Operation
4.3.11. Analysis by Application Area
4.3.12. Logo Landscape: Analysis by Key Players, Scale of Operation and Geography
4.4. Cell Therapy Reagent Providers: List of Players
4.4.1. Analysis by Year of Establishment
4.4.2. Analysis by Company Size
4.4.3. Analysis by Location of Headquarters
4.4.4. Analysis by Location of Reagent Preparation Facilities
4.4.5. Analysis by Accreditations Received
4.4.6. Analysis by Type of End-User
4.4.7. Analysis by Type of Cell Therapy
4.4.8. Analysis by Type of Function
4.4.9. Analysis by Scale of Operation
4.4.10. Analysis by Application Area
4.4.11. Logo Landscape: Analysis by Key Players, Scale of Operation and Geography

5. COMPANY COMPETITIVENESS ANALYSIS

5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.3.1. Company Competitiveness: Kit Providers
5.3.2. Company Competitiveness: Media Providers
5.3.3. Company Competitiveness: Reagent Providers

6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS

6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Bio-Techne
6.4. Miltenyi Biotec
6.5. Sartorius
6.6. STEMCELL Technologies
6.7. Thermo Fisher Scientific

7. COMPANY PROFILES

7.1. Chapter Overview
7.2. BD Biosciences
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Bio-Techne
7.3.1. Company Overview
7.3.2. Product Portfolio
7.3.3. Recent Developments and Future Outlook
7.4. CellGenix
7.4.1. Company Overview
7.4.2. Product Portfolio
7.4.3. Recent Developments and Future Outlook
7.5. Corning
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
7.6. Irvine Scientific
7.6.1. Company Overview
7.6.2. Product Portfolio
7.6.3. Recent Developments and Future Outlook
7.7. Lonza
7.7.1. Company Overview
7.7.2. Product Portfolio
7.7.3. Recent Developments and Future Outlook
7.8. Miltenyi Biotec
7.8.1. Company Overview
7.8.2. Product Portfolio
7.8.3. Recent Developments and Future Outlook
7.9. Sartorius
7.9.1. Company Overview
7.9.2. Product Portfolio
7.9.3. Recent Developments and Future Outlook
7.10. STEMCELL Technologies
7.10.1. Company Overview
7.10.2. Product Portfolio
7.10.3. Recent Developments and Future Outlook
7.11. Thermo Fisher Scientific
7.11.1. Company Overview
7.11.2. Product Portfolio
7.11.3. Recent Developments and Future Outlook

8. RECENT DEVELOPMENTS AND INITIATIVES

8.1. Chapter Overview
8.2. Cell Therapy Consumables: Recent Partnerships and Collaborations
8.2.1. Analysis by Year of Partnership
8.2.2. Analysis by Type of Partnership
8.2.3. Analysis by Year and Type of Partnership
8.2.4. Analysis by Type of Consumable
8.2.5. Analysis by Type of Partnership and Type of Consumable
8.2.6. Analysis by Type of Cell Therapy
8.2.7. Analysis by Type of Consumable and Type of Cell Therapy
8.2.8. Most Active Players: Analysis by Number of Partnerships
8.2.9. Analysis by Region
8.2.9.1. Intracontinental and Intercontinental Agreements
8.2.9.2. Local and International Agreements
8.2.10. Analysis by Year of Acquisition
8.2.11. Analysis by Type of Acquisition
8.2.12. Analysis by Key Value Drivers
8.2.13. Analysis by Year of Acquisition and Key Value Drivers
8.3. Cell Therapy Consumables: Recent Expansions
8.3.1. Analysis by Year of Expansion
8.3.2. Analysis by Purpose of Expansion
8.3.3. Analysis by Year and Purpose of Expansion
8.3.4. Analysis by Type of Consumable
8.3.5. Analysis by Purpose of Expansion and Type of Consumable
8.3.6. Analysis by Area of Expansion
8.3.7. Analysis by Region
8.3.7.1. Analysis by Location of Consumable Facility (Continent-wise)
8.3.7.2. Analysis by Location of Consumable Facility (Country-wise)
8.3.8. Analysis by Purpose of Expansion and Location of Headquarters

9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS

9.1. Chapter Overview
9.2. Scope and Methodology
9.3. Key Potential Strategic Partners for Cell Therapy Consumable Providers
9.3.1. Likely Partner Opportunities for Dendritic Cell Therapy Consumable Providers
9.3.2. Likely Partner Opportunities for NK Cell Therapy Consumable Providers
9.3.3. Likely Partner Opportunities for Stem Cell Therapy Consumable Providers
9.3.4. Likely Partner Opportunities for T-Cell Therapy Consumable Providers

10. DEMAND ANALYSIS

10.1. Chapter Overview
10.2. Scope and Methodology
10.3. Global Demand for Cell Therapy Consumables
10.4. Global Demand for Cell Therapy Consumables for Planar Processes
10.5. Global Demand for Cell Therapy Consumables for Suspension Processes
10.6. Analysis by Scale of Operation
10.7. Analysis by Region

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS

11.1. Chapter Overview
11.2. Scope and Limitations
11.3. Key Assumptions and Forecast Methodology
11.4. Global Cell Therapy Consumables Market, 2021-2031
11.5. Cell Therapy Consumables Market, 2021-2031: Distribution by Type of Consumable
11.5.1. Cell Therapy Consumables Market for Kits, 2021-2031
11.5.2. Cell Therapy Consumables Market for Media, 2021-2031
11.5.3. Cell Therapy Consumables Market for Reagents, 2021-2031
11.6. Cell Therapy Consumables Market, 2021-2031: Distribution by Type of Cell Therapy
11.6.1. Cell Therapy Consumables Market for Dendritic Cell Therapy, 2021-2031
11.6.2. Cell Therapy Consumables Market for NK Cell Therapy, 2021-2031
11.6.3. Cell Therapy Consumables Market for Stem Cell Therapy, 2021-2031
11.6.4. Cell Therapy Consumables Market for T-Cell Therapy, 2021-2031
11.7. Cell Therapy Consumables Market, 2021-2031: Distribution by Scale of Operation
11.7.1. Cell Therapy Consumables Market for Clinical Operations, 2021-2031
11.7.2. Cell Therapy Consumables Market for Commercial Operations, 2021-2031
11.8. Cell Therapy Consumables Market, 2021-2031: Distribution by Type of End- User
11.8.1. Cell Therapy Consumables Market for Industry Players, 2021-2031
11.8.2. Cell Therapy Consumables Market for Non-Industry Players, 2021-2031
11.9. Cell Therapy Consumables Market, 2021-2031: Distribution by Geography
11.9.1. Cell Therapy Consumables Market in North America, 2021-2031
11.9.2. Cell Therapy Consumables Market in Europe, 2021-2031
11.9.3. Cell Therapy Consumables Market in Asia-Pacific, 2021-2031
11.9.4. Cell Therapy Consumables Market in Rest of the World, 2021-2031

12. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES

12.1. Chapter Overview
12.2. Emerging Trends Related to Cell Culture Media
12.3. Key Challenges Associated with Animal-derived Media Components
12.4. Advantages of Using Animal-free Media

13. IMPACT OF COVID-19 ON CELL THERAPY CONSUMABLES

13.1. Chapter Overview
13.2. Impact of COVID-19 Pandemic on Cell Therapy Consumables Market
13.3. Impact on Future Market Opportunities for Cell Therapy Consumable Providers
13.4. Current Opinions and Key Initiatives of Key Players
13.4.1. Strategies for Implementation in the Short / Mid Term
13.4.2. Strategies for Implementation in the Long Term

14. CONCLUDING REMARKS

15. INTERVIEW TRANSCRIPTS

16. APPENDIX I: TABULATED DATA

17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures
Figure 2.1 Executive Summary: Market Landscape
Figure 2.2 Executive Summary: Recent Developments
Figure 2.3 Executive Summary: Demand Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Type of Cell Therapy Consumable
Figure 4.1 Cell Therapy Consumables: Distribution by Type of Consumable
Figure 4.2 Cell Therapy Kit Providers: Distribution by Year of Establishment
Figure 4.3 Cell Therapy Kit Providers: Distribution by Company Size
Figure 4.4 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Figure 4.5 Cell Therapy Kit Providers: Distribution by Location of Kit Preparation Facilities
Figure 4.6 Cell Therapy Kit Providers: Distribution by Accreditations Received
Figure 4.7 Cell Therapy Kit Providers: Distribution by Type of End-User
Figure 4.8 Cell Therapy Kits: Distribution by Type of Cell Therapy
Figure 4.9 Cell Therapy Kits: Distribution by Type of Function
Figure 4.10 Cell Therapy Kits: Distribution by Scale of Operation
Figure 4.11 Cell Therapy Kits: Distribution by Application Area
Figure 4.12 Regional Landscape: Distribution of Kit Providers by Application Area and Geography
Figure 4.13 Cell Therapy Media Providers: Distribution by Year of Establishment
Figure 4.14 Cell Therapy Media Providers: Distribution by Company Size
Figure 4.15 Cell Therapy Media Providers: Distribution by Location of Headquarters
Figure 4.16 Cell Therapy Media Providers: Distribution by Location of Media Preparation Facilities
Figure 4.17 Cell Therapy Media Providers: Distribution by Accreditations Received
Figure 4.18 Cell Therapy Media Providers: Distribution by Type of End-User
Figure 4.19 Cell Therapy Media: Distribution by Type of Cell Therapy
Figure 4.20 Cell Therapy Media: Distribution by Media Components
Figure 4.21 Cell Therapy Media: Distribution by Type of Function
Figure 4.22 Cell Therapy Media: Distribution by Scale of Operation
Figure 4.23 Cell Therapy Media: Distribution by Application Area
Figure 4.24 Regional Landscape: Distribution of Media providers by Application Area and Geography
Figure 4.25 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Figure 4.26 Cell Therapy Reagent Providers: Distribution by Company Size
Figure 4.27 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Figure 4.28 Cell Therapy Reagent Providers: Distribution by Location of Reagent Preparation Facilities
Figure 4.29 Cell Therapy Reagent Providers: Distribution by Accreditations Received
Figure 4.30 Cell Therapy Reagent Providers: Distribution by Type of End-User
Figure 4.31 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Figure 4.32 Cell Therapy Reagents: Distribution by Type of Function
Figure 4.33 Cell Therapy Reagents: Distribution by Scale of Operation
Figure 4.34 Cell Therapy Reagents: Distribution by Application Area
Figure 4.35 Regional Landscape: Distribution of Reagent Providers by Application Area and Geography
Figure 4.36 Grid Representation: Distribution by Type of Consumable, Type of Cell Therapy and Application Area
Figure 5.1 Company Competitiveness: Cell Therapy Kit Providers
Figure 5.2 Company Competitiveness: Cell Therapy Media Providers
Figure 5.3 Company Competitiveness: Cell Therapy Reagent Providers
Figure 6.1 Brand Positioning Matrix: Bio-Techne
Figure 6.2 Brand Positioning Matrix: Miltenyi Biotec
Figure 6.3 Brand Positioning Matrix: Sartorius
Figure 6.4 Brand Positioning Matrix: STEMCELL Technologies
Figure 6.5 Brand Positioning Matrix: Thermo Fisher Scientific
Figure 7.1 Miltenyi Biotec: Product Portfolio
Figure 7.2 STEMCELL Technologies: Product Portfolio
Figure 7.3 Bio-Techne: Product Portfolio
Figure 7.4 Irvine Scientific: Product Portfolio
Figure 7.5 Thermo Fisher Scientific: Product Portfolio
Figure 7.6 Sartorius: Product Portfolio
Figure 7.7 BD Biosciences: Product Portfolio
Figure 7.8 Lonza: Product Portfolio
Figure 7.9 CellGenix: Product Portfolio
Figure 7.10 Corning: Product Portfolio
Figure 8.1 Partnerships and Collaborations: Distribution by Year of Partnership
Figure 8.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 8.3 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Figure 8.4 Partnerships and Collaborations: Distribution by Type of Consumable
Figure 8.5 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Figure 8.6 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Figure 8.7 Partnerships and Collaborations: Distribution by Type of Consumable and Type of Cell Therapy
Figure 8.8 Most Active Players: Distribution by Number of Partnerships
Figure 8.9 Partnerships and Collaborations: Intracontinental and Intercontinental Agreements
Figure 8.10 Partnerships and Collaborations: Local and International Agreements
Figure 8.11 Mergers and Acquisitions: Year-wise Cumulative Trend, 2016-2021
Figure 8.12 Mergers and Acquisitions: Distribution by Type of Acquisition
Figure 8.13 Mergers and Acquisitions: Distribution by Key Value Drivers
Figure 8.14 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Figure 8.15 Recent Expansions: Distribution by Year of Expansion
Figure 8.16 Recent Expansions: Distribution by Purpose of Expansion
Figure 8.17 Recent Expansions: Distribution by Year and Purpose of Expansion
Figure 8.18 Recent Expansions: Distribution by Type of Consumable
Figure 8.19 Recent Expansions: Distribution by Purpose of Expansion and Type of Consumable
Figure 8.20 Recent Expansions: Distribution by Area of Expansion
Figure 8.21 Recent Expansions: Distribution by Location of Consumable Facility (Continent-wise)
Figure 8.22 Recent Expansions: Distribution by Location of Consumable Facility (Country-wise)
Figure 8.23 Recent Expansions: Distribution by Location of Headquarters and Purpose of Expansion
Figure 10.1 Global Demand for Cell Therapy Consumables, 2021-2026 (Million Liters)
Figure 10.2 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026 (Million Liters)
Figure 10.3 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026 (Million Liters)
Figure 10.4 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Figure 10.5 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Figure 10.6 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Region (Million Liters)
Figure 10.7 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Region (Million Liters)
Figure 11.1 Global Outsourced Cell Therapy Consumables Market, 2021-2031 (USD Million)
Figure 11.2 Outsourced Cell Therapy Consumables Market: Distribution by Type of Consumable
Figure 11.3 Outsourced Cell Therapy Consumables Market for Kits, 2021-2031 (USD Million)
Figure 11.4 Outsourced Cell Therapy Consumables Market for Media, 2021-2031 (USD Million)
Figure 11.5 Outsourced Cell Therapy Consumables Market for Reagents, 2021-2031 (USD Million)
Figure 11.6 Outsourced Cell Therapy Consumables Market: Distribution by Type of Cell Therapy
Figure 11.7 Outsourced Cell Therapy Consumables Market for Dendritic Cell Therapy, 2021-2031 (USD Million)
Figure 11.8 Outsourced Cell Therapy Consumables Market for NK Cell Therapy, 2021-2031 (USD Million)
Figure 11.9 Outsourced Cell Therapy Consumables Market for Stem Cell Therapy, 2021-2031 (USD Million)
Figure 11.10 Outsourced Cell Therapy Consumables Market for T-Cell Therapy, 2021-2031 (USD Million)
Figure 11.11 Outsourced Cell Therapy Consumables Market: Distribution by Scale of Operation
Figure 11.12 Outsourced Cell Therapy Consumables Market for Clinical Operations, 2021-2031 (USD Million)
Figure 11.13 Outsourced Cell Therapy Consumables Market for Commercial Operations, 2021-2031 (USD Million)
Figure 11.14 Outsourced Cell Therapy Consumables Market: Distribution by Type of End-User
Figure 11.15 Outsourced Cell Therapy Consumables Market for Industry Players, 2021-2031 (USD Million)
Figure 11.16 Outsourced Cell Therapy Consumables Market for Non-Industry Players, 2021-2031 (USD Million)
Figure 11.17 Outsourced Cell Therapy Consumables Market: Distribution by Region
Figure 11.18 Outsourced Cell Therapy Consumables Market in North America, 2021-2031 (USD Million)
Figure 11.19 Outsourced Cell Therapy Consumables Market in Europe, 2021-2031 (USD Million)
Figure 11.20 Outsourced Cell Therapy Consumables Market in Asia-Pacific, 2021-2031 (USD Million)
Figure 11.21 Outsourced Cell Therapy Consumables Market in Rest of the World, 2021-2031 (USD Million)
Figure 14.1 Concluding Remarks: Overall Market Overview
Figure 14.2 Concluding Remarks: Recent Developments
Figure 14.3 Concluding Remarks: Demand Analysis
Figure 14.4 Concluding Remarks: Market Sizing and Opportunity Analysis
Figure 14.5 Concluding Remarks: Market Sizing and Opportunity Analysis

List of Tables
Table 3.1 Cell Therapies: Applications
Table 3.2 Differences between Cell Therapy and Biotechnology Product
Table 3.3 Key Cell Therapy Manufacturing Steps
Table 3.4 Types of Media Used in Cell Therapy Manufacturing
Table 7.1 Miltenyi Biotec: Key Highlights
Table 7.2 Miltenyi Biotec: Product Portfolio
Table 7.3 STEMCELL Technologies: Key Highlights
Table 7.4 STEMCELL Technologies: Product Portfolio
Table 7.5 STEMCELL Technologies: Recent Developments and Future Outlook
Table 7.6 Bio-Techne: Key Highlights
Table 7.7 Bio-Techne: Product Portfolio
Table 7.8 Bio-Techne: Recent Developments and Future Outlook
Table 7.9 Irvine Scientific: Key Highlights
Table 7.10 Irvine Scientific: Product Portfolio
Table 7.11 Irvine Scientific: Recent Developments and Future Outlook
Table 7.12 Thermo Fisher Scientific: Key Highlights
Table 7.13 Thermo Fisher Scientific: Product Portfolio
Table 7.14 Thermo Fisher Scientific: Recent Developments and Future Outlook
Table 7.15 Sartorius: Key Highlights
Table 7.16 Sartorius: Product Portfolio
Table 7.17 Sartorius: Recent Developments and Future Outlook
Table 7.18 BD Biosciences: Key Highlights
Table 7.19 BD Biosciences: Product Portfolio
Table 7.20 Lonza: Key Highlights
Table 7.21 Lonza: Product Portfolio
Table 7.22 CellGenix: Key Highlights
Table 7.23 CellGenix: Product Portfolio
Table 7.24 CellGenix: Recent Developments and Future Outlook
Table 7.25 Corning: Key Highlights
Table 7.26 Corning: Product Portfolio
Table 8.1 Cell Therapy Consumables: List of Partnerships and Collaborations, 2016-2021
Table 8.2 Cell Therapy Consumables Partnerships and Collaborations: Information on Type of Agreement (Region-wise and Geography-wise), 2016-2021
Table 8.3 Mergers and Acquisitions: Information on Key Value Drivers, 2016-2021
Table 8.4 Cell Therapy Consumables: List of Recent Expansions, 2016-2021
Table 9.1 Key Potential Strategic Partners for Cell Therapy Consumable Providers
Table 9.2 Likely Partners for Dendritic Cell Therapy Consumable Providers
Table 9.3 Likely Partners for NK Cell Therapy Consumable Providers
Table 9.4 Likely Partners for Stem Cell Therapy Consumable Providers
Table 9.5 Likely Partners for T-Cell Therapy Consumable Providers
Table 15.1 Cellular Engineering Technologies: Key Highlights
Table 15.2 HiMedia Laboratories: Key Highlights
Table 16.1 Cell Therapy Consumables: Distribution by Type of Consumable
Table 16.2 Cell Therapy Kit Providers: Distribution by Year of Establishment
Table 16.3 Cell Therapy Kit Providers: Distribution by Company Size
Table 16.4 Cell Therapy Kit Providers: Distribution by Location of Headquarters
Table 16.5 Cell Therapy Kit Providers: Distribution by Location of Kit Preparation Facilities
Table 16.6 Cell Therapy Kit Providers: Distribution by Accreditations Received
Table 16.7 Cell Therapy Kit Providers: Distribution by Type of End-User
Table 16.8 Cell Therapy Kits: Distribution by Type of Cell Therapy
Table 16.9 Cell Therapy Kits: Distribution by Type of Function
Table 16.10 Cell Therapy Kits: Distribution by Scale of Operation
Table 16.11 Cell Therapy Kits: Distribution by Application Area
Table 16.12 Cell Therapy Media Providers: Distribution by Year of Establishment
Table 16.13 Cell Therapy Media Providers: Distribution by Company Size
Table 16.14 Cell Therapy Media Providers: Distribution by Location of Headquarters
Table 16.15 Cell Therapy Media Providers: Distribution by Location of Media Preparation Facilities
Table 16.16 Cell Therapy Media Providers: Distribution by Accreditations Received
Table 16.17 Cell Therapy Media Providers: Distribution by Type of End-User
Table 16.18 Cell Therapy Media: Distribution by Type of Cell Therapy
Table 16.19 Cell Therapy Media: Distribution by Media Components
Table 16.20 Cell Therapy Media: Distribution by Type of Function
Table 16.21 Cell Therapy Media: Distribution by Scale of Operation
Table 16.22 Cell Therapy Media: Distribution by Application Area
Table 16.23 Cell Therapy Reagent Providers: Distribution by Year of Establishment
Table 16.24 Cell Therapy Reagent Providers: Distribution by Company Size
Table 16.25 Cell Therapy Reagent Providers: Distribution by Location of Headquarters
Table 16.26 Cell Therapy Reagent Providers: Distribution by Location of Reagent Preparation Facilities
Table 16.27 Cell Therapy Reagent Providers: Distribution by Accreditations Received
Table 16.28 Cell Therapy Reagent Providers: Distribution by Type of End-User
Table 16.29 Cell Therapy Reagents: Distribution by Type of Cell Therapy
Table 16.30 Cell Therapy Reagents: Distribution by Type of Function
Table 16.31 Cell Therapy Reagents: Distribution by Scale of Operation
Table 16.32 Cell Therapy Reagents: Distribution by Application Area
Table 16.33 Partnerships and Collaborations: Distribution by Year of Partnership
Table 16.34 Partnerships and Collaborations: Distribution by Type of Partnership
Table 16.35 Partnerships and Collaborations: Distribution by Year of Partnership and Type of Partnership
Table 16.36 Partnerships and Collaborations: Distribution by Type of Consumable
Table 16.37 Partnerships and Collaborations: Distribution by Type of Partnership and Type of Consumable
Table 16.38 Partnerships and Collaborations: Distribution by Type of Cell Therapy
Table 16.39 Partnerships and Collaborations: Distribution by Type of Consumable and Type of Cell Therapy
Table 16.40 Most Active Players: Distribution by Number of Partnerships
Table 16.41 Partnerships and Collaborations: Local and International Agreements
Table 16.42 Mergers and Acquisitions: Year-wise Cumulative Trend, 2016-2021
Table 16.43 Mergers and Acquisitions: Distribution by Type of Acquisition
Table 16.44 Mergers and Acquisitions: Distribution by Key Value Drivers
Table 16.45 Mergers and Acquisitions: Distribution by Year of Acquisition and Key Value Drivers
Table 16.46 Recent Expansions: Distribution by Year of Expansion
Table 16.47 Recent Expansions: Distribution by Purpose of Expansion
Table 16.48 Recent Expansions: Distribution by Year and Purpose of Expansion
Table 16.49 Recent Expansions: Distribution by Type of Consumable
Table 16.50 Recent Expansions: Distribution by Purpose of Expansion and Type of Consumable
Table 16.51 Recent Expansions: Distribution by Area of Expansion
Table 16.52 Recent Expansions: Distribution by Location of Consumable Facility (Continent-wise)
Table 16.53 Recent Expansions: Distribution by Location of Consumable Facility (Country-wise)
Table 16.54 Recent Expansions: Distribution by Location of Headquarters and Purpose of Expansion
Table 16.55 Global Demand for Cell Therapy Consumables, 2021-2026 (Million Liters)
Table 16.56 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026 (Million Liters)
Table 16.57 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026 (Million Liters)
Table 16.58 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Table 16.59 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Scale of Operation (Million Liters)
Table 16.60 Global Demand for Cell Therapy Consumables for Planar Process, 2021-2026: Distribution by Region (Million Liters)
Table 16.61 Global Demand for Cell Therapy Consumables for Suspension Process, 2021-2026: Distribution by Region (Million Liters)
Table 16.62 Global Outsourced Cell Therapy Consumables Market, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.63 Outsourced Cell Therapy Consumables Market: Distribution by Type of Consumable, 2021 and 2030
Table 16.64 Outsourced Cell Therapy Consumables Market for Kits, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.65 Outsourced Cell Therapy Consumables Market for Media, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.66 Outsourced Cell Therapy Consumables Market for Reagents, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.67 Outsourced Cell Therapy Consumables Market: Distribution by Type of Cell Therapy, 2021 and 2030
Table 16.68 Outsourced Cell Therapy Consumables Market for Dendritic Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.69 Outsourced Cell Therapy Consumables Market for NK Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.70 Outsourced Cell Therapy Consumables Market for Stem Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.71 Outsourced Cell Therapy Consumables Market for T- Cell Therapy, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.72 Outsourced Cell Therapy Consumables Market: Distribution by Scale of Operation, 2021 and 2030
Table 16.73 Outsourced Cell Therapy Consumables Market for Clinical Operations, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.74 Outsourced Cell Therapy Consumables Market for Commercial Operations, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.75 Outsourced Cell Therapy Consumables Market: Distribution by Type of End-User, 2021 and 2030
Table 16.76 Outsourced Cell Therapy Consumables Market for Industry Players, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.77 Outsourced Cell Therapy Consumables Market for Non-Industry Players, Conservative, Base and Optimistic Scenarios, 2021-2031 (USD Million)
Table 16.78 Outsourced Cell Therapy Consumables Market: Distribution by Geography, 2021 and 2030
Table 16.79 Outsourced Cell Therapy Consumables Market in North America, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.80 Outsourced Cell Therapy Consumables Market in Europe, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.81 Outsourced Cell Therapy Consumables Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)
Table 16.82 Outsourced Cell Therapy Consumables Market in Rest of the World, Conservative, Base and Optimistic Scenario, 2021-2031 (USD Million)

Companies Mentioned
The following companies / institutes / government bodies and organizations have been mentioned in this report.

1. 3P Biopharmaceuticals

2. Accellta

3. Acer Therapeutics

4. Activartis Biotech

5. Adaptimmune

6. Adicet Bio

7. Aduro Biotech

8. Advent Bioservices

9. AGC Biologics

10. AgenTus Therapeutics

11. Agilent Technologies

12. Ajinomoto

13. Akadeum Life Sciences

14. Akron Biotech

15. Allele Biotechnology and Pharmaceuticals

16. Allife Medical Science and Technology

17. Allogene Therapeutics

18. Altor BioScience

19. American CryoStem

20. Amphera

21. AMSBIO

22. Anhui Kedgene Biotechnology

23. ANI Pharmaceuticals

24. apceth Biopharma

25. Applied Biological Materials

26. Arbele

27. Arcline Investment Management

28. Argos Therapeutics

29. Aspire Health Science

30. Astellas Pharma

31. Asterias Biotherapeutics

32. AstraZeneca

33. Atara Biotherapeutics

34. ATCC

35. Athersys

36. Atlantis Bioscience

37. Atreca Therapeutics

38. Aurora Biopharma

39. Austrianova

40. Autolus

41. Avantor

42. AVAX Technologies

43. Axol Bioscience

44. Basic Pharma

45. Baxalta

46. Baxter

47. BD Biosciences

48. Beijing Biohealthcare Biotechnology

49. Beijing Doing Biomedical

50. Beijing Immunochina Medical Science & Technology

51. Beijing Sanwater Biological Technology

52. Beijing Tricision Biotherapeutics

53. Beike Biotechnology

54. Bellicum Pharmaceuticals

55. Bio Elpida

56. BioAtla

57. BioCardia

58. BioCare

59. BioCentriq

60. Bio-Connect

61. Bioinova

62. Biological Industries

63. BioNTech

64. BioRestorative Therapies

65. Bio-Techne

66. bluebird bio

67. Bone Therapeutics

68. BrainStorm Cell Therapeutics

69. Bristol-Myers Squibb

70. C3i (Center of Excellence for Cellular Therapy)

71. Caladrius Biosciences

72. Capricor Therapeutics

73. Captain T Cell

74. CardioCell

75. Carina Biotech

76. CARsgen Therapeutics

77. CAR-T (Shanghai) Biotechnology

78. Cartherics

79. Catalent Biologics

80. Celgene

81. Celixir

82. Cell and Gene Therapy Catapult

83. Cell Applications

84. Cell Biologics

85. Cell Biotech

86. Cell Genesys

87. Cell Therapies

88. Cellaria

89. Cell-Easy

90. Cellectis

91. Cellex Cell Professionals

92. CellGenix

93. Cellin Technologies

94. Cellmed

95. CellMP (A subsidiary of Emmecell)

96. CELLnTEC Advanced Cell Systems

97. CellPraxis

98. CellProtect Nordic Pharmaceuticals

99. CellProthera

100. Cells Online

101. Cellular Biomedicine Group

102. Cellular Engineering Technologies

103. Cellular Therapeutics

104. Celonic

105. Celprogen

106. Celularity

107. Celyad

108. Censo Biotechnologies

109. CHA Biolab

110. Chengdu MedGenCell

111. China Regenerative Medicine International

112. CiMaas

113. Clean Cells

114. CO.DON

115. Cogent Biosciences

116. Cognate BioServices

117. CoImmune

118. Cook MyoSite

119. Corestem

120. Corning

121. Creative Biolabs

122. CRISPR Therapeutics

123. Cyagen Biosciences

124. Cytiva (A subsidiary of Danaher)

125. Cytopeutics

Please contact our Customer Support Center to get the complete Table of Contents